Moreover, finding target molecules, such as epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), ROS1, and programmed death ligand 1 (PD-L1), is significantly important for making treatment decisions in patients with lung cancer. This evidence concerns the gene CD274 and lung carcinoma.